返回打新列表

TANG CAPITAL ACQUISITION CORP. TCAA

已申报

NASDAQ Capital · 美元

发行信息

价格区间
$25.00
发行股数
3,000,000
超额配售
—
募资额
$7,500.00万
发行后总股本
3,000,000
流通比例
100.00%
发行费用
$70.00万
交易所
NASDAQ Capital

公司与限制期

CEO
Kevin Tang
员工
5 (as of 10/06/2026)
注册州
—
财年截止
12/31
锁定期
180 天
静默期结束
—

锁定期到期后内部人与早期投资者可以卖出;静默期结束后承销商才会发布研究报告。

业务简介(招股书摘录,英文)

Tang Capital Acquisition Corp., or TCAA, is a newly formed company incorporated as a Cayman Islands exempted company for the purpose of effecting a merger, share exchange, asset acquisition, share purchase, reorganization or similar business combination with one or more businesses or entities, which we refer to as our initial business combination. TCAA is, we believe, the first no-promote special purpose acquisition company, or np-SPACTM, as described on the cover of this prospectus, and is structured to more closely align the interests of the SPAC sponsor with the SPAC investors. Furthermore, as described below, for companies looking to effectuate a go-public transaction, TCAA represents an attractive alternative to: (i) a conventional initial public offering; (ii) a reverse merger into a failed public company; or (iii) a merger with a conventional SPAC. We have not selected any specific business combination target, and we have not, nor has anyone on our behalf, initiated any substantive discussions, directly or indirectly, with any business combination target. We will have 24 months from the effectiveness of the registration statement of which this prospectus forms a part to complete our initial business combination, which we refer to as the completion window. While we may pursue an initial business combination target in any business or industry, we intend to focus our search in the biopharmaceutical industry. Our initial business combination may be with an entity that is controlled by, affiliated with or otherwise related to Tang Capital Management, LLC (Tang Capital), Tang Capital Acquisition Holdings, LLC (our sponsor), our officers or our directors. --- Our executive offices are located at 4747 Executive Drive, Suite 210, San Diego, California 92121, and our telephone number is (858) 200-3830.

申购参考 · 获配 vs 开盘买入

不构成申购建议

开盘与收盘涨幅为示例输入(非预测),请按自己的情景修改。散户通常很难按发行价获配。

风险清单

  • 价格区间可能在路演期间调整,最终以 424B4 定价为准;发行可能推迟或撤回。
  • 开盘价常与发行价差距很大;锁定期到期后可能有集中卖出。

本页不构成申购建议,不评分、不给申购结论、不给新股预估上市价。